Beyond P-Values: Rethinking How We Interpret Data

Author: Denis Avetisyan

A decade of growing concerns about reproducibility is driving a fundamental shift in statistical inference, moving beyond simple significance to prioritize meaningful results and transparent reporting.

Statistical inference is undergoing a period of rapid evolution, driven by developments anticipated between 2016 and 2026 that promise to reshape how data is interpreted and conclusions are drawn, acknowledging the inherent uncertainty in all analytical processes.

This review charts the evolution from traditional significance testing toward a comprehensive ‘Open Science Inference Ecosystem’ encompassing estimation, uncertainty quantification, and alternative approaches like Bayes factors and equivalence testing.

Despite decades of refinement, traditional statistical inference often prioritizes rejecting null hypotheses over quantifying evidence and informing practical decisions. This review, ‘Making Effective Statistical Inferences: From Significance Testing to the Open Science Inference Ecosystem (2016-2026)’, synthesizes recent methodological advances-including compatibility-based approaches using [latex]p[/latex]-values, [latex]S[/latex]-values, and Bayesian workflows-with systemic reforms like preregistration and multiverse analysis. The resulting framework unifies inference into evidence-centric and decision-centric domains, moving beyond single-metric evaluation towards a multidimensional assessment of both statistical compatibility and practical relevance. Will this shift towards a more transparent and nuanced inferential ecosystem ultimately enhance the reproducibility and impact of scientific research?

The Illusion of Significance: Beyond Arbitrary Thresholds

The pervasive reliance on p-values within Null-Hypothesis Significance Testing frequently obscures the practical importance of research findings. A p-value, representing the probability of observing results as extreme as, or more extreme than, those actually obtained, is often misinterpreted as the probability that the null hypothesis is true-a logical fallacy. This misinterpretation, coupled with an emphasis on achieving statistical significance-typically a p-value below 0.05-can lead researchers to prioritize detecting any effect, regardless of its magnitude. Consequently, studies may report statistically significant, yet trivial, effects while overlooking substantively important relationships that fail to reach the arbitrary significance threshold. The focus on p-values thus overshadows the crucial consideration of effect sizes-measures that quantify the strength of a relationship-leading to flawed conclusions and hindering a comprehensive understanding of the phenomena under investigation. [latex]R^2[/latex] and Cohen’s d are examples of effect sizes that should be reported alongside p-values.

The structure of modern scientific publishing and funding often prioritizes novelty and statistical significance over the practical importance of research findings. This creates a system where studies demonstrating a statistically detectable effect – even a small or trivial one – are more likely to be published and receive attention than those investigating potentially important phenomena with results that lack a definitive [latex]p < 0.05[/latex]. Consequently, researchers may be incentivized to pursue narrow research questions designed to yield statistically significant results, rather than addressing broader, more complex problems with potentially greater real-world impact. This focus on ‘statistical significance’ at the expense of ‘meaningful significance’ ultimately slows scientific progress by diverting resources from robust, impactful research and contributing to a growing body of literature filled with statistically significant, yet practically irrelevant, findings.

The pervasive practice of relying on a [latex]p < 0.05[/latex] threshold for statistical significance is increasingly challenged as a flawed cornerstone of scientific inquiry. This research contends that such a dichotomous approach – categorizing results simply as ‘significant’ or ‘not significant’ – obscures crucial information about the magnitude of an effect and how well the data actually support a given hypothesis. Instead of fixating on whether a [latex]p[/latex]-value crosses an arbitrary line, the emphasis should shift towards quantifying effect sizes – providing a measure of the practical importance of a finding – and assessing the overall compatibility of the data with different models. This nuanced approach promotes a deeper understanding of the observed phenomena, moving beyond simple yes/no conclusions to reveal the strength of evidence and potential for real-world impact.

Beyond Binary Judgments: Quantifying Evidence and Model Compatibility

Bayes Factors (BF) quantify the evidence for one hypothesis relative to another, offering a contrast to traditional null hypothesis significance testing (NHST). Instead of producing a binary ‘significant’ or ‘not significant’ conclusion based on p-values, BFs express the relative likelihood of data under two competing models; for example, a BF of 10 indicates the data are ten times more likely under one hypothesis than the other. Unlike p-values, which are affected by sample size, Bayes Factors are standardized and provide a direct measure of evidence. BFs can take values between 0 and infinity, with higher values indicating stronger evidence for the alternative hypothesis, and values less than 1 indicating evidence for the null. Researchers commonly interpret BF values using scales like those proposed by Jeffreys, where, for example, a BF between 3 and 20 is considered anecdotal evidence.

Data-model compatibility is quantified through the examination of confidence intervals. These intervals, constructed around parameter estimates, represent a range of plausible values for the true population parameter given the observed data. A narrower confidence interval indicates greater precision and stronger compatibility between the data and the model’s assumptions. Conversely, a wide interval suggests substantial uncertainty and potentially poor model fit. The interpretation relies on whether the interval contains values consistent with prior knowledge or theoretical expectations; if the hypothesized value falls outside the interval, it suggests the data are not readily compatible with that specific assumption. Importantly, confidence intervals do not represent the probability of the true parameter being within the interval, but rather the proportion of times the interval would contain the true parameter if the same sampling process were repeated many times.

S-values represent an alternative to p-values for quantifying evidence, expressed on an information scale where 1 S-value indicates evidence equivalent to 1 bit of information. Unlike p-values, which measure the probability of observing data as extreme as, or more extreme than, the observed data given a null hypothesis, S-values directly quantify the weight of evidence. This translation is achieved using the formula [latex] S = -log_2(p) [/latex], converting a p-value into an equivalent measure of surprise or information gain. The paper advocates for justifying the choice of alpha level – traditionally 0.05 – based on specific inferential goals, arguing that a pre-defined threshold is less informative than understanding the actual amount of evidence provided by the data, as represented by the S-value. A higher S-value indicates stronger evidence against the null hypothesis, offering a more granular and interpretable assessment than a simple binary ‘significant/not significant’ determination.

Adaptive Inquiry: Methods for Dynamic Data and Evolving Understanding

Sequential testing and adaptive designs represent a methodological approach wherein data is analyzed during the course of a study, allowing for potential modifications to study parameters such as sample size, treatment allocation, or even study termination. This contrasts with traditional fixed designs where all parameters are determined prior to data collection. Interim analyses are conducted at pre-specified time points to assess accumulating evidence; if certain criteria are met – for example, demonstrating overwhelming efficacy or futility – the study may be stopped early for ethical reasons or to maximize efficiency. Adaptations are implemented based on these interim results, potentially reducing the number of participants exposed to ineffective treatments or increasing the power to detect meaningful effects. These designs require careful planning to maintain statistical validity and control for type I error rates, often employing techniques like repeated significance testing or specialized statistical methods to account for the multiple looks at the data.

E-values represent an alternative to p-values for sequential monitoring of data, specifically addressing limitations in maintaining error control with repeated looks at accumulating results. Unlike p-values, which are susceptible to inflation with multiple tests, E-values directly quantify the evidence against the null hypothesis while accounting for the number of data looks. An E-value is defined as the probability of observing an effect as, or more, extreme than the one observed, assuming the null hypothesis is true, and is calculated without stopping rules. A smaller E-value indicates stronger evidence against the null hypothesis; a commonly used threshold for statistical significance is an E-value of 0.05. Critically, E-values preserve the familywise error rate (FWER) without requiring adjustments for multiple comparisons, offering a more reliable assessment of evidence in adaptive and sequential designs.

A Bayesian workflow for data analysis is an iterative process centered around updating beliefs based on observed evidence. This begins with defining a prior probability distribution representing existing knowledge or assumptions about model parameters. Subsequently, a likelihood function quantifies the compatibility of observed data with different parameter values. Combining the prior and likelihood yields a posterior distribution, representing updated beliefs. This posterior then serves as the new prior in subsequent iterations as more data becomes available. Sensitivity analysis, conducted by varying prior specifications or model assumptions, assesses the robustness of conclusions to changes in these inputs, ensuring reliable and well-supported findings. This iterative cycle of prior specification, data analysis, posterior updating, and sensitivity testing allows for continuous refinement of the model and conclusions.

Towards Transparency and Rigor: Reporting and Validation in the Age of Data

The pervasive issue of publication bias, where statistically significant findings are more likely to be published than null or negative results, threatens the integrity of scientific literature. To counter this, initiatives like Registered Reports are gaining traction; these involve peer review before data collection, focusing on the study’s methodology rather than its results. This pre-specification of study designs, coupled with adherence to reporting guidelines such as CONSORT for randomized trials and PRISMA for systematic reviews, dramatically increases transparency. By requiring detailed protocols to be publicly available, researchers are held accountable to their initial plans, minimizing post-hoc modifications driven by desired outcomes. The result is a more accurate and reliable body of evidence, fostering greater trust in scientific findings and reducing wasted research efforts.

Multiverse analysis tackles a fundamental challenge in data science: the inherent subjectivity woven into the analytic process. Rather than presenting a single result derived from one set of choices, this approach systematically explores a range of plausible analytic pathways – different variable transformations, exclusion criteria, or statistical models – and evaluates the consistency of findings across these ‘universes’. By explicitly acknowledging that data can be analyzed in multiple valid ways, researchers can assess the robustness of their conclusions; a result consistently supported across diverse analytic choices is far more convincing than one reliant on a single, potentially arbitrary, approach. This transparent exploration of analytic flexibility doesn’t aim to find the ‘right’ answer, but rather to understand how sensitive findings are to the decisions made during analysis, ultimately building greater confidence – or identifying limitations – in the presented evidence.

Traditional statistical significance testing often focuses on demonstrating effects, yet failing to find a statistically significant result doesn’t necessarily mean there’s no effect – simply that the observed effect isn’t large enough to be considered statistically different from zero. Equivalence testing offers a complementary approach by explicitly testing whether an effect is smaller than a pre-defined, clinically meaningful threshold – the ‘Smallest Effect Size of Interest’. Rather than seeking to prove an effect exists, this method aims to demonstrate the absence of a practically important difference. This is particularly valuable in fields where even small, potentially harmful effects need to be ruled out, or when comparing a new intervention to an existing standard of care – establishing non-inferiority can be just as crucial as demonstrating superiority. By shifting the focus from ‘is there an effect?’ to ‘is the effect meaningfully different from zero?’, equivalence testing provides a more nuanced and informative interpretation of research findings.

Beyond Significance: Towards a New Era of Evidence-Based Understanding

Traditional reliance on statistical significance, often distilled to a p-value threshold, can be misleading; a significant result merely indicates data are improbable given a null hypothesis, not the probability of the hypothesis itself. Increasingly, researchers are adopting methods that directly quantify evidence for or against competing hypotheses. Bayes factors, for instance, express how much more likely observed data are under one hypothesis compared to another, offering a more intuitive measure of support. Similarly, equivalence testing moves beyond seeking to reject a null hypothesis, instead aiming to demonstrate that an effect is negligibly different from zero, or that two treatments are clinically equivalent. This shift towards quantifying the strength of evidence, rather than simply declaring a result ‘significant’ or not, fosters a more nuanced interpretation of research findings and encourages a more comprehensive understanding of complex phenomena.

When researchers investigate numerous possibilities simultaneously – a common practice in fields like genomics and drug discovery – the chance of incorrectly identifying a true effect, known as a Type I error, increases dramatically. Traditional methods focusing on individual p-values struggle to address this ‘multiple comparisons problem’. False Discovery Rate (FDR) control offers a powerful solution by shifting the focus from controlling the probability of any false positives to controlling the proportion of identified effects that are actually false. Instead of demanding an impossibly low significance level for each test, FDR control allows for a pre-specified acceptable proportion of false discoveries – for example, accepting that 5% of reported effects might be spurious. This approach provides a more pragmatic and statistically sound method for drawing reliable conclusions from large-scale studies, ultimately strengthening the foundation of scientific knowledge by minimizing misleading findings.

Scientific advancement increasingly benefits from strategies designed to enhance research integrity and efficiency. Adaptive designs, which allow for modifications to a study based on accumulating data, coupled with pre-specification of analyses through Registered Reports, represent a powerful shift toward transparency and rigor. By requiring detailed study plans – including hypotheses, methods, and analytical approaches – before data collection, Registered Reports mitigate issues like publication bias and p-hacking. This proactive approach not only strengthens the validity of findings but also streamlines the publication process, focusing peer review on the quality of the research question and methodology rather than post-hoc interpretations. The culmination of a decade’s worth of reform in statistical inference, these practices collectively promise to accelerate the pace of discovery and build greater trust in scientific conclusions.

The pursuit of statistical inference, as outlined in the paper, isn’t about definitively proving a hypothesis, but rather subjecting it to rigorous scrutiny. This echoes Aristotle’s observation: “It is the mark of an educated mind to be able to entertain a thought without accepting it.” The document highlights the limitations of solely relying on p-values-a practice that often prioritizes rejecting null hypotheses over meaningfully estimating effect sizes. This focus on disproof, rather than comprehensive understanding, invites the very kind of rationalization of variance the paper seeks to correct. A truly robust inference ecosystem, therefore, demands a discipline of uncertainty, repeatedly challenging assumptions and embracing the possibility of being wrong, even when initial evidence appears convincing.

What’s Next?

The move beyond ritualistic significance testing, as outlined in this work, isn’t about finding ‘the truth,’ but about acknowledging how little of it any single study can legitimately claim. The field now faces a practical challenge: translating conceptually sound alternatives – Bayes factors, compatibility intervals, equivalence testing – into accessible tools and, crucially, a shift in ingrained reporting cultures. Every dataset is, after all, just an opinion from reality, and a statistically ‘significant’ result offers only a weak vote of confidence, easily swayed by the next, inevitably contradictory, finding.

A truly robust inference ecosystem demands embracing uncertainty, not masking it. Expect to see increasing pressure for pre-registration, data sharing, and the routine reporting of effect sizes alongside variance – the devil isn’t in the details, but in the outliers. However, methodological advances alone won’t suffice; the greatest hurdle remains overcoming the incentives that reward positive results and penalize null findings.

The coming decade will likely witness a proliferation of sequential analysis techniques, allowing for adaptive study designs and more efficient use of data. But the ultimate test won’t be statistical sophistication; it will be whether the field can resist the temptation to tell a compelling story at the expense of honest data interpretation. Rationality isn’t emotionless – it’s the discipline of uncertainty, and a willingness to admit when an opinion needs revision.

Original article: https://arxiv.org/pdf/2603.22594.pdf

Contact the author: https://www.linkedin.com/in/avetisyan/